Michael Hunter, MD
Neurology · Murray, UTNPI 1376939827
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $26,538 of the $32,705 with a category attached, or 81.1%. Amgen accounts for 98.5% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $32,216, more than ten times the $290 reported in 2019.
Across 42 payments — averaging $778.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$32K
- UCB, Inc.$146
- Nevro Corp.$140
- CSL Behring$99
- AstraZeneca$56
- Sarepta Therapeutics, Inc.$24
- plus $24 from 1 others
What the payments were for
- Consulting fees$3,43811%
- Speaking & faculty fees$26,53881%
- Travel & lodging$2,0266%
- Food & beverage$7042%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 33 | $32,216 |
| UCB, Inc. | 3 | $146 |
| Nevro Corp. | 1 | $140 |
| CSL Behring | 1 | $99 |
| AstraZeneca | 2 | $56 |
| Sarepta Therapeutics, Inc. | 1 | $24 |
| Argenx US, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UPLIZNA$3,691
- Senza Spinal Cord Stimulation System$140
- Zilbrysq$119
How this compares
$32,705 in reported general payments places this provider in the 85th percentile of 157 neurology providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EvrysdiRisdiplam | 16 | $429,565 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 35 | $231,292 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 42 | $197,439 |
| Azathioprine | 29 | $7,836 |
| Pyridostigmine Bromide | 57 | $4,553 |
| Pregabalin | 125 | $3,874 |
| Mycophenolate Mofetil | 18 | $2,965 |
| Duloxetine Hcl | 84 | $1,873 |
| Gabapentin | 57 | $1,213 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 26 | $731 |
| Lamotrigine | 35 | $721 |
| Nortriptyline Hcl | 41 | $712 |
| MethotrexateMethotrexate Sodium | 28 | $644 |
| Levetiracetam | 20 | $616 |
| Baclofen | 17 | $575 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $99 | $197,43942 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 157 neurology providers in Utah.
Other neurology in Murray
- Nigel HarrisonMurray$41K
- Heston ArnoldMurray$20K
- Evan BlackMurray$15K
- Maya ThomasMurray$3K
- Kathleen McKeeMurray$3K
- Timothy WestSalt Lake City$856K
- Richard HammondOgden$707K
- Jeffrey GrovesDraper$628K
- Stacey SteevesSalt Lake City$548K
- Amir ArainSalt Lake City$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.